October 09, 2026 08:45 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Restriction, not complete closure’: Supreme Court questions Delhi shutdown ahead of CJP protest | 'Unwarranted': India hits back at JD Vance over ‘indentured servants’ remark amid US Green Card crackdown | US targets Microsoft, Infosys, Tata in green card crackdown | ‘Bold and inventive’: Canadian poet Anne Carson wins 2026 Nobel Prize in Literature | ‘Attempt to destabilise world’s largest democracy’: 42 retired judges rally behind Gyanesh Kumar over ‘vote chori’ row | ‘Vote chor, gaddi chod’: Dhruv Rathee, Prakash Raj join Bengaluru protest against Gyanesh Kumar | India condemns Houthi attacks on Saudi airports, calls targeting of civilian infrastructure unacceptable | Dalal Street bloodbath: Investors lose Rs. 8 lakh crore as Sensex crashes over 1,000 points | Amazon layoffs hit India, US and UK: Fresh job cuts rock e-commerce giant amid festive shopping season | Bollywood mourns Nana Patekar: Anupam Kher, Akshay Kumar, Jr NTR, Suniel Shetty pay emotional tributes
Bangladesh Vaccine Trial

Bangladesh government rejects Chinese COVID-19 trial

| @indiablooms | Oct 15, 2020, at 06:11 pm

Dhaka: The clinical trial in Bangladesh of an experimental COVID-19 vaccine developed by Sinovac Biotech has now become uncertain after the country's health ministry expressed unwillingness towards co-financing the initiative as requested by the Chinese drugmaker.

On Sept 22, Sinovac wrote to the health minister saying they were planning to begin the phase 3 test of the vaccine candidate, CoronaVac, in August. But the firm spent the funds in another country as the Bangladesh government had delayed giving the go-ahead to the trials, reports bdnews24.

Sinovac said it was not sure about getting the final approval from Bangladesh. They appealed to the Coalition for Epidemic Preparedness Innovation or CEPI for funds to run the trial in Bangladesh but never received it, the news portal reported.

The company hence wanted the Bangladesh government to invest money to run the safety trial.

Sinovac should run the trial with their own money because that’s what they said they would do when they had sought approval, Health Minister Zahid Maleque told bdnews24

“(And) that’s why they were given permission,” he said.

“They also said they will provide us 100,000 doses of the vaccine free of charge. We approved the trial after they wrote to us following discussions on all of these issues.”

His ministry checked, first via the icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh) and then directly, with Sinovac when the planned trial of the vaccine candidate did not begin following the regulatory approval, Maleque said.

“A country’s job is done when it approves the clinical test of a vaccine. They never asked for co-funding when they sought approval for the trial. This is not a contract we have with the Chinese government. This is a private company and we cannot have a co-funding (arrangement) with a private company," the Minister said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.